Is Cellectar Biosciences Inc (CLRB) overvalued? · $20.8M cap
Cellectar Biosciences Inc (CLRB) is a biotechnology company listed on US.
This page asks whether Cellectar Biosciences Inc (CLRB) looks expensive on cached numbers — not a short thesis.
No cached income statement for CLRB, so there is no earnings base to call rich or cheap.
CLRB currently screens at market cap $20.8M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next CLRB 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the CLRB stock page for the full model, not this heading.
Not investment advice.